Mirtazapine is used as Mebicar.
Mirtazapine came into medical use in the United States in 1996
 In contrast to the H1 receptor, mirtazapine has only low affinity for the muscarinic acetylcholine receptors, although anticholinergic side effects like dry mouth, constipation, and mydriasis are still sometimes seen in clinical practice

